Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Phoenix Molecular Imaging
Information provided by (Responsible Party):
Fabio Almeida MD, Phoenix Molecular Imaging Identifier:
First received: February 4, 2012
Last updated: April 1, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)